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Background: Consistent and appropriate measurement is needed in order to improve understanding 
and evaluation of preventative interventions. This review aims to identify individual-level measurement 
tools used to evaluate mental health prevention interventions to inform harmonisation of outcome 
measurement in this area.  
Methods: Searches were conducted in PubMed, PsychInfo, CINAHL, Cochrane and OpenGrey for 
studies published between 2008 and 2018. that aimed to evaluate prevention interventions for common 
mental health problems in adults and used at least one measurement scale (PROSPERO 
CRD42018095519). For each study, mental health measurement tools were identified and reviewed for 
reliability, validity, ease-of-use, and cultural sensitivity. 
Results: 127 studies were identified that used 65 mental health measurement tools. Most were used by 
a single study (57%, N = 37) and measured depression (N = 20) or overall mental health (N = 18). The 
most commonly used questionnaire (15%) was the Centre for Epidemiological Studies Depression Scale 
(CES-D). A further 125 tools were identified which measured non- mental health specific outcomes. 
Conclusions: There was little agreement in measurement tools used across mental health prevention 
studies, which may hinder comparison across studies.  Future research on measurement properties and 
acceptability of measurements in applied and scientific settings could be explored. Further work on 
supporting researchers to decide on appropriate outcome measurement for prevention would be 
beneficial for the field. 









Depression, the most prevalent diagnosis of mental health problems, currently represents one of the 
leading causes of disability globally,1 and the number of people living with a common mental health 
problem (defined by the National Institute of Health and Care Excellence as depression and anxiety 
disorders) is increasing.2-4 Prevention of common mental health problems, such as depression, remain 
an important area of focus for improving public health and reducing demand on public services. 
Taking a prevention-based approach to mental health problems involves a public-health model of 
action, with interventions directed toward entire populations (universal), groups known to have higher 
risk of mental health problems (selective), and those already displaying early symptoms (indicated).5 
Mental health prevention interventions are therefore interventions which aim to prevent common mental 
health problems at one of those three levels.   
Both prevention and promotion interventions consider a wide range of risk and protective factors which 
can be understood at the individual, family, community, and population-wide levels. Characteristics 
may also include age, gender, culture, income, experiences, and education.6 Currently, a wide range of 
measures appear to be used by academics and stakeholders with little guidance on key, or core outcomes 
to be used by researchers. In order to improve comparability of findings in mental health prevention 
research, it has been recommended that data collection and evaluation methods are aligned and more 
consistent use is made of robust standardised measures to allow for the improved use of data across 
larger and smaller-scale projects, routine outcome measurement, and trials.7  
A comprehensive overview of the range of measurement tools currently used in the literature to evaluate 
mental health prevention interventions can serve as a valuable resource for researchers, practitioners, 
and policymakers and represents an initial step toward more standardised measurement across 
prevention projects. Utilising a consistent suite of robust measurement tools can enable more direct 
comparison of results across studies, allowing for easier consolidation of research findings and aiding 
the ability to draw generalisable conclusions that inform policy and practice.  
This review aims to systematically identify the range of measurement tools currently used to evaluate 





The protocol for the systematic review was registered on PROSPERO (CRD42018095519) in May 
2018. Recent studies which aimed to evaluate preventative interventions for common mental health 
problems (depression, anxiety disorders, PTSD, and OCD).4 were identified through a series of 
electronic searches conducted in PubMed, PsychINFO, CINAHL, Cochrane, and OpenGrey databases. 
Search terms were a combination of terms in the title or abstract indicative of: adults, non-clinical 
populations, mental health, prevention, and measurement. Search strategies are presented in Appendix 
I. Appropriate standardised vocabulary and truncation were used for each database. Only those studies 
published in English, between January 2008 and May 2018 were included.  
Inclusion and Exclusion Criteria 
To be eligible for inclusion, studies had to: be published between January 2008-May 2018 (last search 
date: 18/05/2018), involve evaluation (using at least one measurement scale) of  an intervention with a 
non-clinical adult population (mean age of 16-65 without a mental health diagnosis) and have a primary 
aim of improving mental health and preventing a common mental health problem. This included 
universal, selective, and indicated mental health prevention intervention.5  
Studies were excluded from analysis if: they had a primary aim of preventing conditions or behaviours 
other than common mental health problems, including psychosis, schizophrenia, bipolar disorder, eating 
disorders, dementia, substance abuse, gambling, suicide, or domestic abuse; they had a primary aim 
other than the prevention of mental health problems (e.g. promotion of subjective wellbeing or overall 
health-related quality of life); they worked with a population that met clinical threshold for a mental 
health problem at baseline; they did not involve a direct intervention (e.g. prevalence studies, measure 
development and validation studies); they did not report use of a measurement scale. 
Within included studies, specific measurement tools were excluded if they: focussed on populations 
secondary to the intervention (e.g. children in interventions targeted to parents, or individuals with 
chronic conditions in interventions targeted to caregivers) or focussed solely on the severity of a chronic 
physical condition (e.g. diabetes or cancer). Measurement tools were also excluded if they were bespoke 
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tools developed specifically for the study (e.g. not a pre-existing standardised measurement tool); were 
an existing tool that had been modified specifically for the study (e.g. changing questionnaire wording, 
question order, or overall length); were a subscale of an existing tool used in isolation of the full measure 
(e.g. use of only the anxiety subscale of a general symptom inventory). It has been suggested that these 
practices can reduce the transparency of measurement in a study and introduce researcher degrees of 
freedom.8  
Systematic review and meta-analysis studies were also excluded, however, the reference lists of reviews 
identified by the search strategy and deemed relevant to mental health prevention were hand-searched 
for additional eligible records. 
Record Screening 
Initial title and abstract screening were conducted by a single researcher (VZ) supervised by JB. The 
full text of articles included from the initial screening were then screened according to the inclusion 
criteria by both VZ and a second independent reviewer (ES or EU). Conflicts were discussed within the 
study team, and if necessary, resolved by JB and EU.  
Data Extraction and Synthesis 
Data from included records were extracted by VZ and ES, with a subset of 10% of records reviewed for 
accuracy by a third reviewer (EU).  
The following data were extracted from each included study: basic information about the study (author, 
year of publication, country, aim), information about the sample (age, gender, ethnicity), information 
about the intervention (intervention description, setting, primary and secondary outcomes) and 
information about measurement (measurement tools used for evaluation of outcomes). Each unique 
measurement tool identified during the initial extraction was listed and categorised by target construct 
(the outcome the tool is designed to measure). The target constructs were then coded by VZ into the 
following higher-order categories: symptoms, diagnosis, functioning, protective factors, risk factors, 
cognitive factors, quality of life, wellbeing, help-seeking, cost-effectiveness, and other. Given the focus 
of the study on the prevention of common mental health problems, measures categorised as measures 
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of mental health symptoms or diagnosis were selected for secondary extraction. Measures in the 
remaining categories were summarised descriptively.  
Following identification of mental health measurement tools, secondary literature searches were 
conducted for papers providing further information about the characteristics (e.g. psychometrics, 
development, terms of use) of each tool. Extraction of measurement tool characteristics captured: basic 
information about the measure (developer, year, target population), psychometric properties (content, 
construct, and criterion validity, internal consistency, and test-retest reliability), practicability (number 
of items, costs, terms of use, administration method, availability of normative data), and sensitivity 
(cultural sensitivity). The checklist was developed by VZ and was pilot tested by ES and EU and revised 
following use on a sample of initial records. 
Assessment of Quality 
The criteria for evaluating the psychometric properties, and quality of the investigation of psychometric 
properties were drawn from the validity and reliability sections of the Medical Outcomes Trust 
Scientific Advisory Committee Guidance on Evaluating Quality of Life and Health Status Instruments.9 
Evidence for cultural sensitivity was assessed using criteria similar to those used in a systematic review 
of subjective wellbeing measurement tools10  and was assessed as the availability of translations of the 
measure in languages other than English, or the validation or successful use of the measure with 
individuals from diverse cultures. Each characteristic was rated as “present”, “not present”, “mixed”, 
or “unknown”.  
Systematic review of the literature regarding the properties of each individual measure was beyond the 
scope of the current study. Non-systematic literature searches were conducted for each tool. Where 
multiple research articles were available which assessed the psychometric properties of a measure, the 
recommendations outlined in Greenhalgh et al., (1998) were followed.11 Preference was given to the 
record which described the original development of the tool, or the next closest record (in terms of year 
and author involvement) if the original record was inaccessible. Where a systematic review or meta-
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analysis of psychometric properties was available, a critical reading of the review was used as evidence 
of psychometric properties.  
Results 
Identification of Prevention Evaluation Studies 
Searches identified a total of 11,962 records, 1,911 duplicate records were excluded leaving 10,051 
records eligible for initial screening. Of these, 9,222 records were found to be irrelevant at the title and 
abstract screening stage, leaving 829 full-text studies eligible for secondary screening.  
Of these, a further 712 studies were deemed ineligible due to not meeting one or more of the inclusion 
criteria. Most studies were excluded due to prevention of common mental health problems not being 
the stated primary aim, or due to non-intervention study designs.  
A total of 117 studies met inclusion criteria. Four of these records were published trial protocols for 
trials with results also included in full by the search criteria. As the trial protocol and the study findings 
will both contain information about the measurement tools used, the records for the published protocol 
and published finding were combined to avoid double-counting the use of measurement tools. This 
resulted in 113 unique studies. An additional 14 studies were identified by hand-searching reference 
lists from relevant systematic reviews and meta-analyses. Within these 127 studies (Figure 1), 65 unique 
mental health measurement tools (symptom inventories and diagnostic measures) were identified and 
125 non-mental health specific measurement tools were identified (measures of functioning, protective 
and risk factors, cognitive factors, quality of life, wellbeing, help-seeking, cost-effectiveness and other). 
Description of Included Studies 
Characteristics of included studies are summarised in Table 1. Identified studies took place mainly in 
the USA or Canada (41%, n = 52), used selective approaches (targeted to groups or populations known 
to have higher risk) (54%, n = 69), and 25 % (n=32) were targeted toward pregnant women or new 
mothers.  
Most approaches were based on cognitive-behavioural therapy (CBT) (21%, n = 27), followed by 
combined interventions comprising a mix of approaches (e.g. CBT, psychoeducation, peer support etc.) 
8 
 
(19%, n = 24), and exclusively psychoeducation (16%, n = 20). The remaining studies used other 
psychological approaches (e.g. problem-solving therapy) (n = 14), mindfulness (n = 9), physical 
exercise (n = 7), counselling (n = 6), skills-training (n = 5), creative approaches (e.g. singing or arts 
classes) (n = 4), and peer mentoring (n = 3). A total of eight studies (6%) used other approaches that 
included parenting interventions, web-based decision aids, and dietary changes. 
Symptom change was used to evaluate the preventative intervention in 65% of studies (n = 83). Sixteen 
percent of studies (n = 20) included a type of diagnostic assessment (i.e. incidence, onset, or time-to-
onset, or use of established ‘cut-offs’ or ‘thresholds’ on continuous symptom measures). There was 
overlap between these approaches and 19% (n = 24) measured both symptoms and diagnostic indicators 
as outcomes. In terms of the specific outcomes measured, depression (either symptoms or diagnosis) 
was an outcome in 75% of included studies (n = 95). This was followed by anxiety (39%, n = 49), 
overall mental health (i.e. psychological distress) (21%, n = 27), PTSD (9%, n = 12) and OCD (1%, n 
= 1). There was substantial overlap between these categories and many studies measured more than one 
outcome. 
Description of Common Mental Health Measurement Scales 
Included measurement tools were developed between 1953 and 2010 (median = 1994). Just over one 
third (34%, n = 22) were developed for use (or recommended by developers for use) in both clinical 
and non-clinical populations, 26% (n = 17) for the general population, 23% (n = 15) for clinical 
populations, and 14% (n = 9) for specific sub-groups such as new mothers, military members, trauma 
survivors, or individuals with specific chronic illnesses.  
Sixty-five unique measurement tools which measured mental health symptoms or diagnosis were 
identified. Of these, 56 assessed symptoms and nine were diagnostic interviews. Of the symptom 
measurement tools, 18 focussed on overall mental health symptomatology (i.e. covered a range of 
symptoms from across categories of common mental health problems) and 20 focussed on depression. 
The remainder focussed on anxiety (n = 9), PTSD (n = 8) and OCD (n = 1).  
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The most commonly reported measure overall was the Centre for Epidemiologic Studies Depression 
Scale (CES-D)12 which was used by 15.0% (n = 19) of studies. Most measurement tools identified (57%, 
n = 37) were only used by a single study. Use of measurement tools was more consistent when looking 
within specific mental health outcome categories, for example, within only those studies that included 
depression as an outcome, 20% (n = 19) used the CES-D.  Outcome measurement was also more 
consistent when considering evaluation of the prevention of postnatal depression. The Edinburgh 
Postnatal Depression Scale (EPDS)13 is targeted toward pregnant women and new mothers and was one 
of the most commonly used tools both within this group (53.1%, n = 17) and across all included studies 
(13.4%, n = 17).  
Twenty-three studies (18.1%) measured prevention by using a diagnostic interview, of which the 
Mini-International Neuropsychiatric Interview (MINI)14 (n = 9) and any version of the Structured 
Clinical Interview for DSM (SCID) (n = 9) were most commonly used.  
The most commonly used tools to capture depression, anxiety, and general mental health are presented 
in Table 2. Their frequency of use is presented both across all included studies (n = 127) and within 
those studies that specified depression (n = 95), anxiety (n = 49), or general mental health (n = 27) as 
an outcome. As many studies measured more than one of these outcomes or utilised a general mental 
health measurement tool to capture outcomes of anxiety or depression, these categories are not mutually 
exclusive and percentages for use within categories may sum to more than 100%.  
Psychometrics 
Based on the literature reviewed to assess the psychometrics of the identified tools (original 
development papers or systematic reviews where available), included tools generally had adequate 
reliability and validity to assess mental health symptoms, and a majority (69.2%, n = 45) were validated 
and/or translated in multiple languages. The studies establishing psychometric properties of the tools 
were generally of mixed quality. Over half (58.5%) of identified tools (n = 38) met at least five of eight 
quality criteria, and 41.5% (n = 27) did not. This may reflect in part the pragmatic approach to reviewing 
the psychometric literature, in which original development papers, many of which are older publications 
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that may not reflect current standards in reporting, were used to assess psychometrics. The psychometric 
properties for the most frequently used tools are presented in Table 3. 
For evaluation of depression prevention interventions, the CES-D and the Patient Health 
Questionnaire (PHQ-9)15 were the most widely used, freely available measurement tools. At 20 items, 
the CES-D is longer than the PHQ-9 (nine-items) and so may be more appropriate for research where 
participant burden (the demands placed on participant time as part of participation in a research study) 
is less of a concern. Both tools are available in a range of languages,16,17 are recommended by 
developers as appropriate for a general, non-clinical population, and have evidence to support their 
validity, internal consistency, and test-retest reliability.12,18,19 For anxiety, the seven-item Generalised 
Anxiety Disorder measure (GAD-7)20 was the most widely used tool. The GAD-7 has been translated 
into multiple languages, is appropriate for use in a general, non-clinical population, and has evidence 
to support its validity, internal consistency, and test-retest reliability.16,20 For measurement of a range 
of mental health symptoms, the 21-item Depression, Anxiety, Stress Scale (DASS-21)21 was the most 
widely used, freely available, self-reported tool. It is appropriate for use with a general, non-clinical 
population and has evidence available to support its validity and internal consistency.22,23 It has been 
successfully used in a variety of cultures and countries and is available in multiple translated 
versions.24  
Practicability 
The majority of tools are administered through self-report (73.8%, n = 48). We were unable to find clear 
details on terms of use for 29.2% (n = 19) of the scales. Of those with terms of use instructions available, 
half (50.0%, n = 23) were free-to-use, 45.7% (n = 21) had costs associated with use, and 4.3% (n = 2) 
varied between free use and paid use dependent on the type of work and funding source. 
In addition to fees for use, 7.7% (n = 5) had restrictions on the type of work tools could be used for (e.g. 
not to be used for commercial gain), 7.7% (n = 5) had restrictions on the access and production of 
translated versions, 7.7% (n = 5) had restrictions on how the tool could be administered (e.g. paper copy 
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or online), and 3.1% (n = 2) required specific training prior to use. For 24.6% (n = 16) it was unclear if 
there were additional restrictions on use. 
Description of Non-Mental Health Specific Measurement Tools 
Across the 127 studies, a further 125 measurement tools were identified which measured outcomes 
other than symptoms or diagnoses of common mental health problems. Most outcome measurement 
tools classified as measuring “non-mental health specific” constructs, measured outcomes that are 
protective (n = 42) and risk factors (n = 28) presumed to contribute to increased or decreased risk of 
onset and/or increase of symptomatology.  
Protective outcomes included measures of positive psychological constructs (e.g. compassion, hope, 
engagement, optimism, self-efficacy, and spirituality) as well as overall resilience, and behaviours or 
social and environmental factors which support good mental health (e.g. physical activity, job 
satisfaction, social support, coping-skills, and relationship quality).  
Risk outcomes included overall measures of general stress and fatigue, as well as risk-behaviours 
(substance use) and environmental or social factors associated with increased risk of mental health 
problems (e.g. caregiving burden, parenting stress and practices, sleep quality, experience of trauma, 
exposure to domestic violence and abuse). 
In addition to risk and protective outcomes, non-mental health specific outcome measures captured: 
cognitive factors (n = 18) (individual thought processes such as rumination, decision-making, problem-
solving, or mindfulness), quality of life (n = 11), wellbeing (n = 8), general functioning (n = 8), help-
seeking (n = 3), cost-effectiveness (n = 3) and other (mental health literacy, mental health stigma, and 
sexual functioning) (n = 4). It is beyond the scope of the current paper to further evaluate these 







The present study provides an overview of the measures used to evaluate the effectiveness of 
interventions that prevent common mental health problems. It gives insight into the range of outcome 
measures used, and the ones most frequently used. This information is a first step in developing a 
potential future common outcomes framework for measuring the effect of preventative interventions in 
mental health.  
Our findings suggest heterogeneity in measures used for evaluating the prevention of common mental 
health problems. Across 127 studies, 65 measurement tools were identified for measuring mental health 
problems and a further 125 were identified which measured non-mental health specific constructs. The 
most commonly reported tool, (CES-D), was only used in 19 out of 127 studies. 
We identified several frequently used measures which were freely accessible with adequate 
psychometric properties. The most frequently used, freely accessible, tools included the CES-D and 
PHQ-9 for prevention of depression and the EPDS for prevention of depression in pregnant women or 
new mothers. The GAD-7 was the most frequently used freely available tool for assessing prevention 
of anxiety and the DASS-21 was the most frequently used, freely available, tool for assessing general 
mental health.  
It should be noted that the PHQ-9 and GAD-7 are commonly used in clinical practice in England as 
part of the routine outcome monitoring component of the Improving Access to Psychological Therapies 
(IAPT) programme.25 As such, use of the PHQ-9 and GAD-7 may have the additional benefit of 
providing results that are more directly comparable to clinical populations in England using routinely 
collected clinical data. It should be noted that the PHQ-9 includes an item regarding suicidal ideation, 
which can potentially raise safeguarding concerns beyond the scope of some community-based 
preventative mental health programmes to appropriately manage. In these instances, researchers may 
wish to consider the eight-item version, which was found to have broadly similar psychometric 
properties, but which excludes the item on suicidal ideation.18  
The range of measurements chosen depend on the aim of the study, however, practical considerations 
also affect this decision. For instance, diagnostic assessments can help to accurately measure the impact 
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of a prevention programme on the incidence of common mental health problems like depression, 
especially when they are applied with a long follow-up. Only 23 studies (18.1%) measured prevention 
by using a diagnostic assessment tool in our review, of which, the Mini-International Neuropsychiatric 
Interview (MINI) and any version of the Structured Clinical Interview for DSM (SCID) were used most 
often. Part of the reason why these measures were not used more frequently may be because they 
commonly require training, expertise and costs for use. In these cases, a commonly used, free and 
validated self-reported tool may be more feasible, especially for voluntary and community sector 
organisations considering local evaluation of their work in prevention. Where budget is not constrained, 
diagnostic outcome assessments may be suitable, pending on the research question being asked. 
To improve the evidence base for prevention, especially in applied settings, more consistency in 
measurement could benefit the field. Evidence suggests that, at a conceptual level, using measures with 
disparate specifications can create confusion when interpreting or comparing effectiveness across 
settings and population groups.26 The use of adapted or bespoke measures may also further introduce 
researcher degrees of freedom to a study.8 Therefore, the evidence base may benefit from taking steps 
toward a common measurement framework that standardises and aligns evaluation of preventative 
interventions in the community. The present review represents a first step toward this goal. By providing 
an overview of the range of measurement tools currently used to evaluate mental health prevention 
interventions, we provide indication of the current degree of alignment and provide measurement tools 
that may be candidates for inclusion in future common measurement framework development. 
Limitations 
The study is limited by the lack of grey literature. Though searches were conducted in Open Grey, a 
database of grey literature, very few relevant results were identified. It is likely that there are a range of 
tools used to evaluate the impact of mental health prevention interventions outside of the academic 
literature which will have been missed from the present review. While many of these tools are likely to 
be bespoke to organisations or projects, it would be valuable to assess any existing standardised tools 
that are commonly used outside of the academic literature, particularly those used in voluntary and 
community sector settings. Furthermore, due to the number of tools included, it was not possible to 
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systematically review the evidence for the psychometric properties of each tool identified by this 
review. Instead, literature reviews were conducted which aimed to utilise critical readings of existing 
systematic reviews and meta analyses where available, and the original development paper, or next 
closest paper in terms of year and author involvement, as evidence of psychometric properties. This is 
a pragmatic approach which adheres to recommendations from Greenhalgh et al., (1998) for reviewing 
and selecting outcome measures for use in routine practice.11 However, due to this, some relevant papers 
regarding the psychometrics for tools identified by this review may have been missed. 
During the process of developing the search strategy and inclusion criteria for this review, it became 
clear that the boundaries between what is, and is not, a mental health prevention intervention can be 
unclear. This is something that has historically been a challenge in conceptualising prevention work in 
mental health.5 In order to apply consistent rules that achieved a manageable number of results we were 
only able to include studies with a stated primary aim of improving mental health in a subclinical 
population or preventing a common mental health problem. This aligns with the criteria suggested by 
Cowen (1980) for identifying and defining primary prevention work.27 However, in doing so, it is 
possible that interventions which had broader and less clearly defined aims, but which were nonetheless 
relevant to the prevention of mental health problems, were excluded from review.  
Implications for Future Research 
While in-depth exploration of the secondary tools identified was beyond the scope of the current review, 
further exploration of the properties of the tools used to capture non-mental health specific outcomes 
would be beneficial for enhancing understanding of how current mental health prevention studies 
measure the secondary and intermediate outcomes of their interventions, and for developing 
recommendations for harmonisation of this aspect of measurement and evaluation.  
In the absence of harmonisation of measurement of preventative interventions, it may be valuable to 
explore alternative strategies to allow movement between different mental health outcome measures, 
for example, the use of mapping approaches like those used to map the relationship between more 
generic quality of life measures and condition-specific measures.28  
15 
 
Many of the commonly used tools identified were developed using items drawn from diagnostic criteria, 
or other validated questionnaires. To our knowledge, few of the most commonly used tools involved 
substantial co-production in the development of the items themselves, though several utilised 
consultation approaches (e.g. piloting and focus groups) to refine items. As such, it will be useful to 
assess the acceptability of tools identified by this review among those populations most likely to be 
participants in mental health prevention interventions. Understanding more about how participants view 
these scales, and their relevance to their own lives and circumstances, can provide support for tools 
being “participant-valued”.29 Participant-valued tools are those that have been produced by researchers 
and clinicians using traditional methods but have been found to reflect the perspectives of participants 
through the use of qualitative research approaches.29 The use of outcome measures that are patient-
valued (and wherever possible, co-produced) is important to ensure that research accurately captures 
the aspects of mental health that are most important to the participants, and therefore has implications 
for both the meaningfulness, and the quality, of the data collected.29 Plans for follow-up qualitative 
research of this kind are currently underway by the co-authors of the current study. 
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Key Points 
• To build the evidence-base for mental health prevention, research should aim to improve 
standardisation of outcome measurement across studies 
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• Currently, there is little consistency across prevention studies in terms of the tools used to 
measure mental health prevention outcomes 
• We propose that the most frequently used and freely available measurement tools identified by 
this review be considered when developing any future common measurement frameworks for the 
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Table 1: Characteristics of included studies 
  N % 
Country 
  
UK 17 13.4 
Other European 24 18.9 
USA & Canada 52 40.9 
Australia & New Zealand 21 16.5 
Asia 9 7.1 
Other 4 3.1 
Preventative Approach 
  
Universal 27 21.3 
Selective 69 54.3 
Indicated 31 24.4 
Population Group 
  
General Population 29 22.8 
Pregnant Women/New Mothers 32 25.2 
Students and Young Adults 23 18.1 
Chronic Physical Illness/Disability 13 10.2 
Families and Caregivers 14 11.0 
Trauma Survivors 5 3.9 





Table 2: Most commonly used measurement tools by outcome  
  Number of Uses % of all studies  
 




(n = 127) (n = 95) 
*CES-D 19 15.0 20.0 
*EPDS 17 13.4 17.9 
BDI-II 16 12.6 16.8 
*PHQ-9 12 9.4 12.6 
Anxiety  (n = 127) (n = 49) 
*GAD-7 7 5.5 14.3 
BAI 4 3.1 8.2 
*PSWQ 4 3.1 8.2 
STAI 4 3.1 8.2 
General Mental Health 
 
(n = 127) (n = 27) 
*DASS-21 12 9.4 44.4 
HADS 9 7.1 33.3 
*PANAS 5 3.9 18.5 
GHQ-12 4 3.1 14.8 



















     
*CES-D + +/- + +/- 
 
BDI-II + +/- + + 
 
*EPDS + + \ \ 
 
*PHQ-9 + + + + 
 
Anxiety 
     
*GAD-7 + + + + 
 
BAI + + + + 
 
*PSWQ + + + + 
 
STAI +/- \ + +/- 
 
General Mental Health 
     
*DASS-21 + \ + \ 
 
HADS + + + \ 
 
*PANAS + + + +/- 
 
GHQ-12 + + + + 
 
*tool is in public domain, or free to use for non-profit research/clinical purposes;   
+, good psychometric values; −, less than optimal psychometric values; ±, not consistent value; \ unknown or 
unclear 
 
 
